APA (7th ed.) Citation

T, P., AM, J., KB, C., Y, Y., A, G., A, J., . . . KS, C. (2019). Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma. Cancer immunology research, 7(10), 1633. https://doi.org/10.1158/2326-6066.CIR-18-0579

Chicago Style (17th ed.) Citation

T, Pazina, et al. "Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma." Cancer Immunology Research 7, no. 10 (2019): 1633. https://doi.org/10.1158/2326-6066.CIR-18-0579.

MLA (9th ed.) Citation

T, Pazina, et al. "Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma." Cancer Immunology Research, vol. 7, no. 10, 2019, p. 1633, https://doi.org/10.1158/2326-6066.CIR-18-0579.